The study on ESG in pharmaceuticals reveals gaps in social criteria compliance despite increasing regulatory pressures. Roland Berger categorized companies into three maturity levels—initiators, aspirers, and frontrunners—and identified key areas for improvement, such as access to medicines. The findings stress the need for broader engagement in social issues to enhance overall ESG performance.
This new Roland Berger publication explores the potential – and the problems – in bringing proven artificial intelligence (AI) together with emerging quantum technologies. Far from blue-sky thinking, many companies already have this massively lucrative prize firmly in their sights.
How IT executives can respond to key trends in IT – and how companies can get ready for AI IT study 2024 – Trends, challenges and implications.
At CES 2025 in Las Vegas, Roland Berger's experts explored the latest technological trends and innovations that are shaping our future. In our webinar ‘Summing up CES 2025’, you will gain exciting insights from our Partners Falk Meissner, Konstantin Shirokinskiy, Steffen Thiel, Isaac Chan and Nikolaus Lehmann into groundbreaking developments such as AI, autonomous systems and sustainable technologies - and their transformative impact on our world. Further information is available here.
, Central Europe
Mathias Heller
Study, October 20, 2024
